Cellaria
675 W. Kendall Street
Cambridge
Massachusetts
02142
United States
Tel: 617-981-4208
Website: https://www.cellariabio.com
Email: support@cellariabio.com
About Cellaria
Cellaria is a scientific innovator that unites some of the foremost minds in cancer research and technology. As a company that is tightly aligned with the research community around the world, we identified a pressing need for a new kind of cancer cell model and made it our unwavering mission to lead, develop, and deliver.YEAR FOUNDED:
2013
LEADERSHIP:
Founder: Elin Agoston
CEO: David Deems
JOBS:
Please click here for Cellaria job opportunities.
PRODUCTS:
All Products
FOLLOW CELLARIA:
Tweets by Cellaria
5 articles about Cellaria
-
Cellaria Inc Launches New Cell Lines to Support the Development of Personalized Therapies for Lung Cancer
5/25/2021
Cellaria Inc (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, now offers five stable, fully authenticated lung cancer cell models to support the development of more effective and targeted drug therapies.
-
Vyant Bio, Inc., Ordaōs Bio, and Cellaria, Inc. Announce Collaboration to Design and Qualify Biomarker-Specific Small Protein Therapeutics
4/22/2021
New collaboration mitigates risk in drug d iscovery process with artificial intelligence and in vitro “avatar” clinical trials
-
Cellaria Inc. Partners With Researchers at Northeastern University to Advance New Photomedicine Therapies for Key Cancers
12/1/2020
Cellaria Inc (Wakefield, MA, USA) and the Spring Lab, Northeastern University, announce the successful receipt of a National Institutes of Health (NIH) R01 grant to extend and advance the application of innovative new photomedicine-based therapies for hard-to-treat cancers. The grant highlights the close working relationshi
-
Cellaria, Inc. Introduces A New Generation Of Cell Line Models For Pancreatic Cancer Paving The Way For Better Treatment
10/15/2020
Cellaria, Inc. (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, has introduced three next generation Pancreatic Cancer cell lines, substantially boosting the value of in vitro methods in the development of more effective therapies. Difficult to detect
-
Cellaria And Biological Industries USA Partner On Stem Cell Media And Research
5/4/2017